Aug 02, 2022

Veramaris sets science-based target to further reduce carbon footprint

Delft, Netherlands, August 2, 2022 – Veramaris has committed to reducing their Greenhouse Gas (GHG) emissions by setting a science-based target which has now been approved by the Science Based Target initiative (SBTi) aimed at urgently limiting global warming to below 1.5°C. Veramaris will achieve a 38% reduction in absolute Scope 1 and Scope 2 emissions by 2030 from a 2021 base year.

Notably, the start-up is making this commitment ahead of its recently announced growth phase. Veramaris will report progress against the Science Based Targets in addition to measuring and reducing Scope 3 emissions.

Veramaris recognises that through its own commitment to decarbonise, it helps customers address their Scope 3 emissions while also creating additional transparency in their supply chains. Indeed, in the food sector, retailers recognise that Scope 3 emissions account for the majority of their GHG emissions, therefore relying on supply chain engagement to help them meet their reduction targets.

Karim Kurmaly, CEO of Veramaris said, “Aligning our Greenhouse Gas reduction goals with Science Based Targets is an important step we are taking to contribute to protecting the future of our planet. At Veramaris, even though we are in the early stages of scaling up our production, we understand the importance and urgency of climate change. So, we are doing our bit to help the food system grow within planetary boundaries.”

GHG concentrations have peaked in recent years prompting scientists and governments to try and limit the global temperature rise to no more than 1.5°C in an attempt to prevent the worst climate impacts on the planet.  It is for this reason that countries and companies worldwide are coming together and taking action to cut emissions.

The Science Based Targets initiative (SBTi) is leading the way to a zero-carbon economy, driving ambitious climate action in the private sector by enabling companies to set science-based emissions reduction targets. Veramaris’ commitment recognises the critical role the private sector can play in the transition to a low-carbon economy while conserving marine biodiversity and therewith helping protect the health of our oceans.

Veramaris Media contacts

Johan Brouwer

Images for download

Follow us on

About Veramaris

Veramaris, headquartered in Delft, The Netherlands, is a joint venture between DSM and Evonik, both world leaders in science and specialty chemicals. Established in 2018, Veramaris was formed to help realise a vision to conserve natural marine life by using the ocean's own resource, natural marine algae, to sustainably expand the world's access to Omega-3.

Veramaris extracts oil from natural marine algae, rich in both the essential Omega-3 fatty acids EPA & DHA, and also ARA, a long chain Omega-6, vital nutrients for improved brain, heart and eye health in both animals and humans.

The zero-waste industrial scale production process runs at a state-of-the-art site in Blair, Nebraska, USA.

Veramaris enables key stakeholders in aquaculture and pet nutrition to become independent of wild-caught fish and meet the growing demand for sustainable seafood and animal protein.

Legal Disclaimer

This information and any recommendations, technical or otherwise, are presented in good faith and believed to be correct as of the date prepared. Recipients of this information and recommendations must make their own determination as to its suitability for their purposes. VERAMARIS EXPRESSLY DISCLAIMS ANY REPRESENTATIONS AND WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, AS TO THE ACCURACY, RELIABILITY, COMPLETENESS, NON-INFRINGEMENT, MERCHANTABILITY AND/OR FITNESS FOR A PARTICULAR PURPOSE (EVEN IF VERAMARIS IS AWARE OF SUCH PURPOSE) WITH RESPECT TO ANY INFORMATION AND RECOMMENDATIONS PROVIDED. IN NO EVENT SHALL VERAMARIS BE LIABLE FOR ANY DAMAGES ARISING FROM OR RELIANCE UPON, OR USE OF, ANY INFORMATION OR RECOMMENDATIONS PROVIDED HEREIN. Reference to any trade names used by other companies is neither a recommendation nor an endorsement of the corresponding product and does not imply that similar products could not be used. Veramaris reserves the right to make any changes to the information and/or recommendations at any time, without prior or subsequent notice.

Go back

Newsroom overview